Nasdaq

Mosaic ImmunoEngineering Expands Its Modular Vaccine Platform (MVP) Through New Technology Licensing Agreement with the University of California San Diego

- Data Supporting the Potential of Lead Vaccine Candidates was Funded Through Competitive Federal Grants and has Been Published in Peer Reviewed Scientific Publications- - MVP Combines Protein ...
Nasdaq

Mosaic ImmunoEngineering Inc. Announces Upgrade to OTCQB Venture Market and Upcoming Presentation at the B. Riley Oncology Investor Conference

NOVATO, CA / ACCESSWIRE / January 19, 2021 / Mosaic ImmunoEngineering Inc., (the "Company" or "Mosaic") (OTC PINK:CPMV), a development-stage biotechnology company focused on bridging immunology and ...